Patents
Patents for C07C 257 - Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines (2,984)
10/2006
10/24/2006US7125879 Prevention reproduction of virus
10/24/2006CA2237650C Benzamidoxime prodrugs as antipneumocystic agents
10/17/2006US7122676 Reacting oxalimidic acid dihydrazide with sodium nitrite
10/17/2006US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/04/2006EP1706375A2 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
10/04/2006EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/03/2006US7115769 Catalyzing the alkylation, forming a 2-alkylcysteine derivatives, a chemical intermediates for iron chelating agents
09/2006
09/28/2006US20060217561 Synthesis of substituted thiazoline carboxylic acids
09/20/2006CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
09/19/2006US7109216 For therapy of psychiatric and neurological disorders
09/14/2006US20060205943 Process for preparing xanthine phosphodiesterase V inhibitors and precursers thereof
09/13/2006CN1830955A Method for synthesizing O-ethoxy phenyl formamidine acetate
09/12/2006US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
09/12/2006US7105502 Releasing nitric oxide; controlling blood pressure; cytotoxic compound
09/07/2006US20060199978 Compounds having serotonin 5-ht17 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
09/06/2006EP1698629A2 Polyamines and their use in therapy
09/06/2006CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
08/2006
08/31/2006WO2006091669A1 Anti-cancer and anti-microbial oxazolidinones and analogues
08/31/2006CA2597667A1 Anti-cancer and anti-microbial oxazolidinones and analogues
08/30/2006EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
08/17/2006WO2005107762A3 Certain chemical entities, compositions, and methods
08/17/2006CA2596646A1 Inhibitors of transthyretin amyloid fibril formation
08/16/2006EP1509525B1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
08/10/2006WO2006084031A1 Imines as ion channel modulators
08/10/2006WO2006083003A1 Novel benzamidine compound
08/10/2006US20060178438 Muscarinic agonists
08/10/2006CA2594505A1 Imines as ion channel modulators
08/09/2006EP1177197B1 Polyamines and their use in therapy
08/08/2006US7087783 Method for preparing nitrogen-containing compounds
08/08/2006US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/03/2006WO2005113011A3 Prodrugs of ion channel modulating compounds and uses thereof
08/03/2006US20060173211 Binaphthol derivatives and their use in optical resolution or optical transformation
08/02/2006EP1215206B1 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
08/01/2006US7084250 asymmetric hydrogenation of 2-[2-acetylamino-3-(4-cyanophenyl)acryloylamino]-2-cyclohexylacetic acid and conversion of the cyano group into the amidine, or a salt thereof, with a 3-(2-amino-2-carbamoylethyl)-1-methylpyridinium salt; claimed intermediates
08/01/2006CA2234611C New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions
07/2006
07/27/2006WO2006077854A1 Method for producing imide ether compound
07/27/2006WO2004033397A3 Activity-based probes, and methods of their preparation and use
07/27/2006US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin
07/13/2006WO2006021833A3 Bisbenzamidines for the treatment of pneumonia
07/11/2006US7074923 Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof
07/11/2006CA2262566C Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
07/06/2006WO2006070878A1 Carboxylic acid derivative or salt thereof
07/05/2006EP1240149B1 Process to prepare aryltriazolinones
07/04/2006US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives
06/2006
06/29/2006US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/29/2006US20060142586 Synthesis of 2-alkyl amino acids
06/29/2006DE102004060248A1 New substituted 3-amino-acrylic acid-imino ester compounds useful as ligands in metal catalysts, which are useful as catalysts in polymerization-, copolymerization- and oligomerization-reactions
06/28/2006EP1254159B9 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides
06/22/2006WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof
06/22/2006WO2005094897A3 Pegylated ion channel modulating compounds
06/22/2006CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof
06/21/2006EP1671945A1 Process for production of 1-aryl-5-(trifluoromethyl)-1h- tetrazoles
06/15/2006US20060128776 Opioid receptor active compounds
06/15/2006US20060128633 Colchinol derivatives as vascular damaging agents
06/08/2006US20060122280 Muscarinic agonists
06/07/2006EP1663960A2 Amidines and derivatives thereof and pharmaceutical compositions containing them
06/07/2006EP1663959A1 Novel amidine compounds for treating microbial infections
06/06/2006CA2136903C Acetic acid derivatives
05/2006
05/31/2006CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
05/18/2006US20060106204 Bifunctional energy-reversible acyl-compositions
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/10/2006EP1254159B1 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/03/2006CN1765893A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
05/03/2006CN1765886A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
05/02/2006US7038073 Synthesis of 2-alkyl amino acids
04/2006
04/27/2006US20060089513 Fluorine compound and fluorinating agent comprising the compound
04/25/2006CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds
04/20/2006WO2006041119A1 Hydrazide derivatives
04/18/2006CA2360943C N2-phenylamidine derivatives
04/13/2006WO2006031556A3 Amidine substituted aryl aniline compounds
04/12/2006EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof
04/11/2006US7026297 Neuroprotective agents
03/2006
03/30/2006US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation
03/29/2006CN1247572C Method of producing nitroguanidine-and nitroenamine derivatives
03/28/2006US7019173 Fluorine compound and fluorinating agent comprising the compound
03/23/2006WO2006031556A2 Amidine substituted aryl aniline compounds
03/22/2006EP1637141A1 Stabilized protease composition comprising a serine protease, morpholino derivatives and reversible inhibitors of said serine protease
03/16/2006WO2006027135A1 4-aminomethyl benzamidine derivatives and their use as factor viiia inhibitors
03/16/2006US20060058389 Novel compounds that inhibit factor xa activity
03/16/2006CA2577608A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
03/15/2006CN1245381C Phenylglycine derivatives
03/14/2006US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
03/09/2006WO2003103598A3 Amidine derivatives for treating amyloidosis
02/2006
02/28/2006US7005450 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
02/28/2006US7005437 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use therof as pharmaceutical compositions
02/21/2006US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety
02/21/2006US7001924 Inhibitors of RNase P proteins as antibacterial compounds
02/21/2006CA2186224C Amidino derivatives useful as nitric oxide synthase inhibitors
02/21/2006CA2184691C L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
02/14/2006US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis
02/14/2006CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
01/2006
01/31/2006US6992221 Production of commercial herbicides: carbonylating an amidrazone of formula (A) with one or more carbonylating agent, or by (ii) condensing a hydrazonoyl derivative of formula (A) with one or more ring-forming agent, wherein
01/26/2006WO2006009590A1 Copper (i) compounds useful as deposition precursors of copper thin films
01/25/2006CN1238338C Process for the preparation of 4(5)-amino-5(4) carboxamidoimidoimidazoles intermediates
01/03/2006US6982335 Synthesis of substituted thiazoline carboxylic acids
12/2005
12/28/2005EP1608617A1 Muscarinic agonists
12/28/2005EP1608354A1 Compounds having serotonin 5-ht7 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
12/28/2005EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/28/2005CN1714079A Mandelic acid derivatives
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 30